Ainsworth Sean's most recent trade in Opus Genetics Inc. was a trade of 79,592 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,592 | 79,592 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc. | Ainsworth Sean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,504 | 167,862 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 41,143 | 88,358 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 35,181 | 35,181 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,976 | 47,215 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,639 | 9,639 | - | - | Stock Option | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 5,000 | 36,239 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Sean Ainsworth | Director | 19 Oct 2022 | 1,574 | 41,239 | - | 0 | Common Stock | ||
| Opus Genetics Inc. | Sean Ainsworth | Director | 19 Oct 2022 | 1,574 | 0 | - | - | Series B Warrant (right to buy) | ||
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 13,394 | 13,394 | - | - | Series A Warrant (right to buy) | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 8,865 | 44,665 | - | - | Common Stock | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 1,574 | 1,574 | - | - | Series B Warrant (right to buy) | |
| Opus Genetics Inc. | Sean Ainsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 5,000 | 5,000 | - | - | Stock Option (right to buy) |